Are Breast Cancer Subtypes Prognostic for Nodal Involvement and Associated with Clinicopathologic Features at Presentation in Early-Stage Breast Cancer?

被引:45
|
作者
Jones, Tiffanie [1 ]
Neboori, Hanmanth [2 ]
Wu, H. [2 ]
Yang, Qifeng [3 ]
Haffty, Bruce G. [2 ]
Evans, Susan [1 ]
Higgins, Susan [1 ]
Moran, Meena S. [1 ]
机构
[1] Yale Univ, Sch Med, New Haven, CT 06520 USA
[2] UMDNJ Robert Wood Johnson Sch Med, New Brunswick, NJ USA
[3] Shangdong Univ, Jinan, Peoples R China
关键词
TRIPLE-NEGATIVE PHENOTYPE; BASAL-LIKE SUBTYPE; MOLECULAR SUBTYPE; CONSERVATION THERAPY; AXILLARY DISSECTION; HORMONE-RECEPTOR; SURVIVAL; OUTCOMES; BIOPSY; WOMEN;
D O I
10.1245/s10434-013-2994-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Breast cancer subtypes (BCS) determined from immunohistochemical staining have been correlated with molecular subtypes and associated with prognosis and outcomes, but there are limited data correlating these BCS and axillary node involvement. This study was conducted to assess whether BCS predicted for nodal metastasis or was associated with other clinicopathologic features at presentation. Patients with stage I/II disease who underwent breast-conserving surgery and axillary surgical assessment with available tissue blocks underwent a institutional pathological review and construction of a tissue microarray. The slides were stained for estrogen receptor, progesterone receptor, and HER-2/neu (HER-2) for classification into BCS. Nodal involvement and other clinicopathologic features were analyzed to assess associations between BCS and patient and tumor characteristics. Outcomes were calculated a function of BCS. The study cohort consisted of 453 patients (luminal A 48.6 %, luminal B 16.1 %, HER-2 11.0 %, triple negative 24.2 %), of which 22 % (n = 113) were node positive. There were no significant associations with BCS and pN stage, node positivity, or absolute number of nodes involved (p > 0.05 for all). However, there were significant associations with subtype and age at presentation (p < 0.001), method of detection (p = 0.049), tumor histology (p < 0.001), race (p = 0.041), and tumor size (pT stage, p < 0.001) by univariate and multivariate analysis. As expected, 10-year outcomes differed by BCS, with triple negative and HER-2 subtypes having the worse overall (p = 0.03), disease-free (p = 0.03), and distant metastasis-free survival (p < 0.01). There is a significant association between BCS and age, T stage, histology, method of detection, and race, but no associations to predict nodal involvement. If additionally validated, these findings suggest that BCS may not be a useful prognostic variable for influencing regional management considerations.
引用
收藏
页码:2866 / 2872
页数:7
相关论文
共 50 条
  • [41] Breast-conserving therapy for early-stage breast cancer
    Mendenhall, NP
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2001, 15 (02) : 219 - +
  • [42] Partial and Whole Breast Irradiation for Early-Stage Breast Cancer
    Haussmann, J.
    Tamaskovics, B.
    Budach, W.
    Boelke, E.
    Corradini, S.
    Djiepmo-Njanang, F-J
    Matuschek, C.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2020, 80 (06) : E23 - E23
  • [43] PROGNOSTIC FACTORS IN EARLY-STAGE TRIPLE NEGATIVE BREAST CANCER (TNBC): THE LIMITS OF CLINICAL AND PATHOLOGICAL FEATURES
    Pecuchet, N.
    Belda, M. Le Frere
    Popovski, T.
    Haouas, S.
    Chamming'S, F.
    Lecuru, F.
    Oudard, S.
    Medioni, J.
    ANNALS OF ONCOLOGY, 2012, 23 : 99 - 99
  • [44] Hypofractionated Whole Breast Irradiation for Early-Stage Breast Cancer
    Braunstein, Lior Z.
    Taghian, Alphonse G.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2015, 313 (13): : 1370 - 1371
  • [45] Locoregional Management of Early-Stage Breast Cancer
    Anderson, Benjamin O.
    Lyons, Janice A.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2020, 18 (07): : 937 - 940
  • [46] Cryotherapy in the Treatment of Early-Stage Breast Cancer
    Ciambella, Chelsey C.
    Takabe, Kazuaki
    WORLD JOURNAL OF ONCOLOGY, 2024, 15 (05) : 737 - 743
  • [47] EARLY-STAGE BREAST-CANCER - THE OPTIONS
    KNOBF, MT
    AMERICAN JOURNAL OF NURSING, 1990, 90 (11) : 28 - 30
  • [48] Survival in Early-Stage Invasive Breast Cancer
    Baker, Jennifer L.
    Hosseini, Ava
    Blue, Michael S.
    Vera, David R.
    Wallace, Anne M.
    ANNALS OF SURGICAL ONCOLOGY, 2014, 21 : 25 - 26
  • [49] Update on the management of early-stage breast cancer
    Heilat, Ghaith Bahjat
    Brennan, Meagan E.
    French, James
    AUSTRALIAN JOURNAL OF GENERAL PRACTICE, 2019, 48 (09) : 604 - 608
  • [50] Treatment of early-stage breast cancer - In brief
    Hurd, TC
    Edge, SB
    Kahlenberg, MS
    Stomper, PC
    Proulx, GM
    Schwartz, G
    Khatri, V
    Winston, JS
    CURRENT PROBLEMS IN CANCER, 1999, 23 (04) : 144 - 228